Metastatic renal cell carcinoma to the pancreas and other sites—a multicenter retrospective studyResearch in context

Metastatic renal cell carcinoma to the pancreas and other sites—a multicenter retrospective studyResearch in context

Summary: Background: Metastatic renal cell carcinoma (mRCC) is a heterogenous disease with poor 5-year overall survival (OS) at 14%. Patients with mRCC to endocrine organs historically have prolonged OS. Pancreatic metastases are uncommon overall, with mRCC being the most common etiology of pancrea...

Full description

Bibliographic Details
Main Authors: Cassandra Duarte, Junxiao Hu, Benoit Beuselinck, Justine Panian, Nicole Weise, Nazli Dizman, Katharine A. Collier, Nityam Rathi, Haoran Li, Roy Elias, Nieves Martinez-Chanza, Tracy L. Rose, Lauren C. Harshman, Dharmesh Gopalakrishnan, Ulka Vaishampayan, Yousef Zakharia, Vivek Narayan, Benedito A. Carneiro, Anthony Mega, Nirmish Singla, Cheryl Meguid, Saby George, James Brugarolas, Neeraj Agarwal, Amir Mortazavi, Sumanta Pal, Rana R. McKay, Elaine T. Lam
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:EClinicalMedicine
Subjects:
Metastatic renal cell carcinoma
Pancreatic metastases
VEGFR
Immunotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023001955

Internet

http://www.sciencedirect.com/science/article/pii/S2589537023001955

Similar Items